Compare Abeona Therapeutics Inc (ABEO) vs Pinterest Inc (PINS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Pinterest Inc — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while Pinterest Inc trades at $22.26 (market cap $12.56B). The key difference: Pinterest Inc is far larger — about 33.6× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | PINS | |
|---|---|---|
Market Cap | $373.32M | $12.56B |
Sector | Health | Media |
52-Week High | $7.23 | $39.17 |
52-Week Low | $4.17 | $15.42 |
Enterprise Value | $228.22M | $12.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Pinterest (PINS) trades at $22.42, up 1.59% with a bullish technical outlook. The company shows strong revenue growth from $2.8B in 2022 to $4.2B in 2025, though net income margin declined to 7.64% in 2026. Recent AI shopping initiatives and Amazon integration highlight strategic moves to boost monetization. Analyst consensus is bullish with a $27.82 price target, representing 24% upside potential from current levels.
PINS presents a growth opportunity with improving fundamentals and strong analyst support, but faces execution risks in monetizing its user base. The stock's elevated P/E ratio of 46.35 requires sustained earnings growth to justify valuation. Competitive pressures in social media and dependency on advertising revenue remain key challenges for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
